Phase 2 Homologous Recombination Deficiency trials recruiting now

All Homologous Recombination Deficiency trials, every phase

Phase 2 Homologous Recombination Deficiency trials

• A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
  NCT04503265 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Bipolar Androgen Therapy + Carboplatin in mCRPC
  NCT03522064 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
  NCT06095141 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Olaparib in Patients With HRD Malignant Mesothelioma
  NCT04515836 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.